Onohara, Daisuke
Suresh, Kirthana Sreerangathama
Silverman, Michael
He, Qi
Kono, Takanori
Padala, Muralidhar http://orcid.org/0000-0003-4304-2449
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1R01HL135145, 1R01HL133667, 1R01HL140325)
Article History
Received: 5 May 2021
Accepted: 23 September 2021
First Online: 7 October 2021
Declarations
:
: Human studies were not carried out by the authors for this article. All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
: M. Padala received consulting fees from Heart Repair Technologies, Inc., and Boston Scientific, which did not have any role in this work, nor did they sponsor and review this submission. M. Padala is a founder of Nyra Medical Inc. and reports significant stock ownership in it, which did not have any role in this study. K. Suresh reports minority stock ownership in Nyra Medical. The other authors declare no competing interests.